# EDGAR Filing Document

**Accession Number:** 0001769759
**File Stem:** 0001104659-25-085618
**Filing Date:** 2025-8
**Character Count:** 11495
**Document Hash:** 035cf43701510c5619253fc8ce69a5d9
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-25-085618.hdr.sgml**: 20250829

**ACCESSION NUMBER**: 0001104659-25-085618

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 16

**CONFORMED PERIOD OF REPORT**: 20250829

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20250829

**DATE AS OF CHANGE**: 20250829

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Monogram Technologies Inc.
- **CENTRAL INDEX KEY:** 0001769759
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 812349540
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41707
- **FILM NUMBER:** 251280548

**BUSINESS ADDRESS:**
- **STREET 1:** 3913 TODD LANE
- **STREET 2:** SUITE 307
- **CITY:** AUSTIN
- **STATE:** TX
- **ZIP:** 78744
- **BUSINESS PHONE:** 512-399-2656

**MAIL ADDRESS:**
- **STREET 1:** 3913 TODD LANE
- **STREET 2:** SUITE 307
- **CITY:** AUSTIN
- **STATE:** TX
- **ZIP:** 78744

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MONOGRAM ORTHOPAEDICS INC
- **DATE OF NAME CHANGE:** 20190305

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**PURSUANT TO SECTION 13 OR 15(d)**

**OF THE SECURITIES EXCHANGE ACT OF 1934**

**Date of report (Date of earliest event reported): August 29, 2025**

**Monogram Technologies Inc.**

**(Exact name of registrant as specified in its charter)**

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-41707** | **81-3777260** |
| **(State or other jurisdiction**<br> **of incorporation)** | **(Commission**<br> **File Number)** | **(I.R.S. Employer**<br> **Identification Number)** |

---

**3919 Todd Lane, Austin, TX 78744**

**(Address of principal executive offices, including zip code)**

**Registrant's telephone number, including area code: (512) 399-2656**

**Not Applicable**

**(Former name or former address, if changed since last report)**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

◻ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

⌧ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

◻ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

◻ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading**<br> **Symbol(s)** | **Name of each exchange**<br> **on which registered** |
| **Common Stock, par value $0.001 per share** | **MGRM** | **The Nasdaq Stock Market** |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ⌧

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻

**Item 7.01 Regulation FD Disclosure**

On August 29, 2025, Monogram Technologies Inc. (the "Company") commenced the distribution of texts and emails to its stockholders to alert such stockholders of the 2025 special meeting of stockholders to approve the acquisition by Zimmer Biomet Holdings, Inc., that was previously announced on July 14, 2025.

The foregoing disclosure is qualified in its entirety by the full text of the texts and emails.

Copies of the texts and emails are attached as Exhibit 99.1, Exhibit 99.2, Exhibit 99.3, and Exhibit 99.4, and are hereby incorporated by reference into this Item 7.01. The information contained in this Current Report on Form 8-K, including Exhibit 99.1, Exhibit 99.2, Exhibit 99.3, and Exhibit 99.4 furnished herewith, is being furnished and shall not be deemed "filed" for any purpose, including for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section and shall not be deemed incorporated by reference into any filing under the Exchange Act or the Securities Act of 1933, as amended, regardless of any general incorporation language in such filing, except to the extent expressly stated in such filing.

**Item 9.01. Financial Statements and Exhibits.**

(d) Exhibits.

---

| | |
|:---|:---|
| **Exhibit <br> Number** | **Description** |
| [99.1](tm2524795d1_ex99-1.htm) | [Monogram Technologies Inc. Text to Registered Holders](tm2524795d1_ex99-1.htm) |
| [99.2](tm2524795d1_ex99-2.htm) | [Monogram Technologies Inc. Text to Street Holders](tm2524795d1_ex99-2.htm) |
| [99.3](tm2524795d1_ex99-3.htm) | [Monogram Technologies Inc. Email to Registered Holders](tm2524795d1_ex99-3.htm) |
| [99.4](tm2524795d1_ex99-4.htm) | [Monogram Technologies Inc. Email to Street Holders](tm2524795d1_ex99-4.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
|  | **MONOGRAM TECHNOLOGIES INC.** |
| Dated: August 29, 2025 | /s/ Benjamin Sexson |
|  | Benjamin Sexson |
|  | Chief Executive Officer |

---

## Exhibit 99.1

**Exhibit 99.1**

Text Message Target Audience: Registered Holders

ACTION REQUESTED - The Monogram Technologies 2025 Special Meeting of Stockholders to approve the acquisition by Zimmer Biomet, is scheduled for September 30th. Please vote your shares now at monogram.vote

Please vote on Monogram's acquisition by Zimmer Biomet. Submit your vote now at monogram.vote

## Exhibit 99.2

**Exhibit 99.2**

Target Audience: Street Holders

ACTION REQUESTED - The Monogram Technologies 2025 Special Meeting of Stockholders to approve the acquisition by Zimmer Biomet, is scheduled for September 30th. Please call (888) 785-6673 now to vote your shares.

## Exhibit 99.3

**Exhibit 99.3**

**Target Audience: Registered Holders**

**Subject: Vote your shares on Monogram's Acquisition by Zimmer Biomet**

Dear Stockholder,

As a stockholder, you have the opportunity to vote on an important proposal. If approved, Zimmer Biomet will be able to acquire Monogram. The special meeting to approve the acquisition is scheduled for September 30, 2025.

**<u>YOUR VOTE IS IMPORTANT!</u>**

**How to Vote:** 

&nbsp;&nbsp;&nbsp;&nbsp;· You'll receive an email from Equity Stock Transfer (<u>noreply@equitystock.com</u>).
 Click *"Vote Now!"* or go to <u>monogram.vote</u> and enter your  **<u>Voting Control Code</u>** .

· If you didn't receive an email, go to <u>monogram.vote</u> and click *"I Can't Find My Voting Control Code."* 

· For assistance, contact <u>proxy@equitystock.com</u> or call 212-575-5757.

If you have any questions or need assistance voting, contact our proxy solicitor, Okapi Partners LLC, toll-free at +1 (888) 785-6673 or email <u>info@okapipartners.com</u>.

**What You're Voting On:**

&nbsp;&nbsp;&nbsp;&nbsp;1. Approve the Agreement and Plan of Merger, under which Zimmer
Biomet will acquire Monogram.

&nbsp;&nbsp;&nbsp;&nbsp;2. Approve the option to adjourn the meeting if more time is needed
to collect votes.

You can review the full proxy statement, which includes the Background of the Merger, Reasons for the Merger, and other important details, on the SEC's website here.

**The Board of Directors recommends voting FOR both proposals.**

**Special Meeting:**

Date: September 30, 2025 at 1:00 PM ET

Location: Online at <u>https://bit.ly/monogramvote</u>

Please take a moment to vote today. Every vote counts!

Thank you for your support,

Monogram Technologies Inc.

**Important Information and Where to Find It**

This communication relates to the proposed transaction involving Monogram Technologies Inc. ("Monogram") and Zimmer Biomet Holdings, Inc. In connection with the proposed transaction, Monogram has filed with the Securities and Exchange Commission ("SEC") a proxy statement on Schedule 14A (the "Proxy Statement"). This communication is not a substitute for the Proxy Statement or any other document that Monogram may file with the SEC or send to its stockholders in connection with the proposed transaction. **STOCKHOLDERS ARE URGED TO READ THE PROXY STATEMENT AND OTHER RELEVANT DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION.**

## Exhibit 99.4

**Exhibit 99.4**

**Target Audience: Street Holders**

**Subject: Vote your shares on Monogram's Acquisition by Zimmer Biomet**

Dear Stockholder,

As a stockholder, you have the opportunity to vote on an important proposal. If approved, Zimmer Biomet will be able to acquire Monogram. The special meeting to approve the acquisition is scheduled for September 30, 2025.

**VOTE YOUR SHARES TODAY!**

**How to Vote:**

&nbsp;&nbsp;&nbsp;&nbsp;· *Y* our broker
 (*Fidelity, Charles Schwab, Robinhood, etc.)* will send you proxy materials including
 your voting instruction form.

&nbsp;&nbsp;&nbsp;&nbsp;· Vote through your
 broker using the link in their email or the "Proxy Voting" section in your account.

If you have any questions or need assistance voting, contact our proxy solicitor, Okapi Partners LLC, toll-free at +1 (888) 785-6673 or email <u>info@okapipartners.com</u>.

**What You're Voting On:**

&nbsp;&nbsp;&nbsp;&nbsp;1. Approve the Agreement
 and Plan of Merger, under which Zimmer Biomet will acquire Monogram.

&nbsp;&nbsp;&nbsp;&nbsp;2. Approve the option
 to adjourn the meeting if more time is needed to collect votes.

You can review the full proxy statement, which includes the Background of the Merger, Reasons for the Merger, and other important details, on the SEC's website <u>here</u>.

**The Board of Directors recommends voting FOR both proposals.**

**Special Meeting:**

Date: September 30, 2025 at 1:00 PM ET

Location: Online at <u>https://bit.ly/monogramvote</u>

Please take a moment to vote today. Every vote counts!

Thank you for your support,

Monogram Technologies Inc.

**Important Information and Where to Find It**

This communication relates to the proposed transaction involving Monogram Technologies Inc. ("Monogram") and Zimmer Biomet Holdings, Inc. In connection with the proposed transaction, Monogram has filed with the Securities and Exchange Commission ("SEC") a proxy statement on Schedule 14A (the "Proxy Statement"). This communication is not a substitute for the Proxy Statement or any other document that Monogram may file with the SEC or send to its stockholders in connection with the proposed transaction. **STOCKHOLDERS ARE URGED TO READ THE PROXY STATEMENT AND OTHER RELEVANT DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION.**